ArticleInternational journal of medical sciences2021

Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.

Eriseld Krasniqi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.